210 related articles for article (PubMed ID: 38406082)
1. Spina Bifida Prevention: A Narrative Review of Folic Acid Supplements for Childbearing Age Women.
Ledet Iii LF; Plaisance CJ; Daniel CP; Wagner MJ; Alvarez I; Burroughs CR; Rieger R; Siddaiah H; Ahmadzadeh S; Shekoohi S; Kaye AD; Varrassi G
Cureus; 2024 Jan; 16(1):e53008. PubMed ID: 38406082
[TBL] [Abstract][Full Text] [Related]
2. Spina bifida and other neural tube defects.
Northrup H; Volcik KA
Curr Probl Pediatr; 2000; 30(10):313-32. PubMed ID: 11147289
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of spina bifida at birth--United States, 1983-1990: a comparison of two surveillance systems.
Lary JM; Edmonds LD
MMWR CDC Surveill Summ; 1996 Apr; 45(2):15-26. PubMed ID: 8602137
[TBL] [Abstract][Full Text] [Related]
5. Neural tube defects: Prevalence, mortality, and maternal characteristics in two departmental hospitals in the northwestern region of Nicaragua, 2006-2018.
Pastora Bucardo DM; González F; Montes Pastora M; Pimienta Ramirez PA; Bonilla IL; Vielot NA; Finnell RH
Birth Defects Res; 2023 May; 115(9):945-953. PubMed ID: 37025002
[TBL] [Abstract][Full Text] [Related]
6. Survival of infants with neural tube defects in the presence of folic acid fortification.
Bol KA; Collins JS; Kirby RS;
Pediatrics; 2006 Mar; 117(3):803-13. PubMed ID: 16510661
[TBL] [Abstract][Full Text] [Related]
7. Pre-conception Folic Acid and Multivitamin Supplementation for the Primary and Secondary Prevention of Neural Tube Defects and Other Folic Acid-Sensitive Congenital Anomalies.
Wilson RD; ; Wilson RD; Audibert F; Brock JA; Carroll J; Cartier L; Gagnon A; Johnson JA; Langlois S; Murphy-Kaulbeck L; Okun N; Pastuck M; ; Deb-Rinker P; Dodds L; Leon JA; Lowel HL; Luo W; MacFarlane A; McMillan R; Moore A; Mundle W; O'Connor D; Ray J; Van den Hof M
J Obstet Gynaecol Can; 2015 Jun; 37(6):534-52. PubMed ID: 26334606
[TBL] [Abstract][Full Text] [Related]
8. Use of vitamins containing folic acid among women of childbearing age--United States, 2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Sep; 53(36):847-50. PubMed ID: 15371968
[TBL] [Abstract][Full Text] [Related]
9. Reducing inequities in preventable neural tube defects: the critical and underutilized role of neurosurgical advocacy for folate fortification.
Estevez-Ordonez D; Davis MC; Hopson B; ; Arynchyna A; Rocque BG; Fieggen G; Rosseau G; Oakley G; ; Blount JP
Neurosurg Focus; 2018 Oct; 45(4):E20. PubMed ID: 30269587
[TBL] [Abstract][Full Text] [Related]
10. Neural tube defects: a review of global prevalence, causes, and primary prevention.
Kancherla V
Childs Nerv Syst; 2023 Jul; 39(7):1703-1710. PubMed ID: 36882610
[TBL] [Abstract][Full Text] [Related]
11. Prevention of neural tube defects with folic acid: The Chinese experience.
Ren AG
World J Clin Pediatr; 2015 Aug; 4(3):41-4. PubMed ID: 26261765
[TBL] [Abstract][Full Text] [Related]
12. Decline in prevalence of neural tube defects in a high-risk region of the United States.
Stevenson RE; Allen WP; Pai GS; Best R; Seaver LH; Dean J; Thompson S
Pediatrics; 2000 Oct; 106(4):677-83. PubMed ID: 11015508
[TBL] [Abstract][Full Text] [Related]
13. Use of dietary supplements containing folic acid among women of childbearing age--United States, 2005.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(38):955-8. PubMed ID: 16195694
[TBL] [Abstract][Full Text] [Related]
14. Gene Environment Interactions in the Etiology of Neural Tube Defects.
Finnell RH; Caiaffa CD; Kim SE; Lei Y; Steele J; Cao X; Tukeman G; Lin YL; Cabrera RM; Wlodarczyk BJ
Front Genet; 2021; 12():659612. PubMed ID: 34040637
[TBL] [Abstract][Full Text] [Related]
15. Spina bifida and anencephaly before and after folic acid mandate--United States, 1995-1996 and 1999-2000.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 May; 53(17):362-5. PubMed ID: 15129193
[TBL] [Abstract][Full Text] [Related]
16. Folic acid intake and spina bifida in the era of dietary folic acid fortification.
Ahrens K; Yazdy MM; Mitchell AA; Werler MM
Epidemiology; 2011 Sep; 22(5):731-7. PubMed ID: 21659881
[TBL] [Abstract][Full Text] [Related]
17. When folic acid fails: Insights from 20 years of neural tube defect surveillance in South Carolina.
Bupp CP; Sarasua SM; Dean JH; Stevenson RE
Am J Med Genet A; 2015 Oct; 167A(10):2244-50. PubMed ID: 26108864
[TBL] [Abstract][Full Text] [Related]
18. Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002.
Williams LJ; Rasmussen SA; Flores A; Kirby RS; Edmonds LD
Pediatrics; 2005 Sep; 116(3):580-6. PubMed ID: 16140696
[TBL] [Abstract][Full Text] [Related]
19. Folate and neural tube defects. Recommendations from a Danish working group.
Rasmussen LB; Andersen NL; Andersson G; Lange AP; Rasmussen K; Skak-Iversen L; Skovby F; Ovesen L
Dan Med Bull; 1998 Apr; 45(2):213-7. PubMed ID: 9587705
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
